In the realm of epidemiology, PASS stands for "Post-Authorization Safety Studies." These are studies conducted after a medical product has been authorized for market use. The primary aim of PASS is to monitor the safety and effectiveness of a product in the general population, providing essential data that can be used for regulatory decision-making.
